SwitchPoint Bio Holding
Wilmington, US · Founded 2025 · Delaware corporation
Founders & leadership
JP
Jussi PaananeninExecutive
SM
Samuel MyllykangasNamed on SEC filing
Board
DP
David ProctorBoard director
Reported raises · per SEC filings
Form D private placements$5.3M disclosed across 1 round · 2026
▶$5.3MraisedMar 2026 · 6 investors · BiotechnologyRule 506(c)
▶$5.3MraisedMar 2026 · 6 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Jussi PaananenExecutive Officer, Director
- David ProctorDirector
- Samuel MyllykangasExecutive Officer, Director
- Offering amount
- $5.3M
- Amount sold
- $5.3M
- Proceeds to insiders
- $600K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has SwitchPoint Bio Holding raised?
- SwitchPoint Bio Holding has disclosed $5.3M raised across 1 round.
- Where is SwitchPoint Bio Holding headquartered?
- SwitchPoint Bio Holding is headquartered in Wilmington, US.